4th Quarter - Report
BROWNSTEIN HYATT FARBER SCHRECK, LLP for SAFE RX
Client
Income
$20,000
Expenses
—
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Alcohol and Drug Abuse ALC
Educating policy makers about anti-pilfering technology known as locking prescription vials (LPVs) Issues relating to establishing a pilot program for LPVs Implementation of PL 114-328, Comprehensive Addiction and Recovery Act of 2016 Implementation of PL 114-198, National Defense Authorization Act for fiscal year 2017-Title III, Section 301
| Lobbyist | Covered position, as disclosed |
|---|---|
| PETER M. GOODLOE | — |
| BRIAN THOMAS MCGUIRE | — |
| WILLIAM MOSCHELLA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.